Why are you selling days before the mid-term analysis on CD12 Serious to Critical Clinical Trial, which could lead to either Emergency Use Authorization (EUA) or Approval itself? Are you insane? They said there are about 45-50 deaths in the mid-term patient population, which means there could be statistical significance. You held your stock to sell now? Are you insane? I am repeating myself now.